LEFT VENTRICULAR LEAD IMPLANTATION FOR DETECTION OF VENTRICULAR ARRHYTHMIAS IN PATIENT WITH IMPLANTABLE CARDIOVERTER DEFIBRILLATOR AND LOW R WAVE IN RIGHT VENTRICLE


LEFT VENTRICULAR LEAD IMPLANTATION FOR DETECTION OF VENTRICULAR ARRHYTHMIAS IN PATIENT WITH IMPLANTABLE CARDIOVERTER DEFIBRILLATOR AND LOW R WAVE IN RIGHT VENTRICLE


Zebrauskaite A1*, Kiernan TJ1,2, Hennessy T1

1Department of Cardiology, University Hospital Limerick, Limerick, Ireland. 2Graduate Entry Medical School, University of Limerick, Limerick, Ireland.


Dilated cardiomyopathy (DCM) is a disease characterised as left ventricular (LV) or biventricular dilatation with impaired systolic function. Regardless of underlying cause patients with DCM have a propensity to ventricular arrhythmias and sudden cardiac death. Implantable Cardioverter Defibrillator (ICD) implantation for these patients results in significant reduction of sudden cardiac death [1-3]. ICD devices may be limited by right ventricle (RV) sensing dysfunction with low RV sensing amplitude. We present a clinical case of patient with DCM, implanted ICD and low R wave sensing on RV lead.


Keywords: DCM, ICD, LV

Free Full-text PDF


How to cite this article:
Zebrauskaite A, Kiernan TJ, Hennessy T. Left Ventricular Lead Implantation for detection of ventricular arrhythmias in Patient with Implantable Cardioverter Defibrillator and low R Wave in Right Ventricle .American Journal of Cardiology Research and Reviews, 2021, 4:17. DOI:10.28933/ajcrar-2021-10-1005


References:
1. Connolly SJ, Gent M, Roberts RS, Dorian P, Roy D, Sheldon RS et al. Canadian implantable de-fibrillator study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation 2000;101:1297–1302.
2. Connolly SJ, Hallstrom AP, Cappato R, Schron EB, Kuck KH, Zipes DP et al. Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg. Canadian Implantable Defibrillator Study. Eur Heart J 2000; 21:2071–2078.
3. Kadish A, Dyer A, Daubert JP, Quigg R, Estes NA, Anderson KP et al. Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evalu-ation Investigators. Prophylactic defibrillator im-plantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med 2004;350:2151–2158.
4. Priori SG, Blomstro C, Mazzanti A, Blom N, Borggrefe M, Camm J et al.2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of theEu-ropean Society of Cardiology. European Heart Journal 2015;36:2793–2867.
5. Al-Khatib SM, Stevenson WG, Ackerman MJ, Bryant WJ, Callans DJ, Curtis AB et al. 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Heart Rhythm. 2017 Nov 3. pii: S1547-5271(17) 31251-1.
6. Wilkoff BL, Fauchier L, Stiles MK, Morillo CA, Al-Khatib SM, Almendral J et al. 2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardiovert-er-defibrillator programmingand testing. J Ar-rhythm 2016;32:1–28.
7. Dekker LR, Schrama TA, Steinmetz FH, Tukkie Rl. Undersensing of VF in a patient withoptimal R wave sensing during sinus rhythm. Pacing Clin Electrophysiol 2004;27:833–4.
8. Lillo-Castellano JM, Marina-Breysse M,1 Gómez-Gallanti A, Martínez-Ferrer JB, Alzueta J, Pérez-Álvarez L et al. Safety threshold of R-wave amplitudes in patients with implantable cardio-verter defibrillator. Heart 2016;102:1662–1670.
9. Lochy S, Francois B, Hollanders G, Provenier F. Left ventricular sensing and pacing for sensing difficulties in internal cardioverter defibrillator therapy for arrhythmogenic right ventricular car-diomyopathy. Europace. 2010 Aug;12(8):1195 -6.


Terms of Use/Privacy Policy/ Disclaimer/ Other Policies:
You agree that by using our site, you have read, understood, and agreed to be bound by all of our terms of use/privacy policy/ disclaimer/ other policies (click here for details)


CC BY 4.0
This work and its PDF file(s) are licensed under a Creative Commons Attribution 4.0 International License.